BEMRIST BREEZHALER

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Lithuania, Poland, South Africa.

Active ingredients

The drug BEMRIST BREEZHALER contains a combination of these active pharmaceutical ingredients (APIs):

1	Indacaterol UNII RYI4401DTM - INDACATEROL ACETATE
	Indacaterol is a partial agonist at the human beta2-adrenergic receptor with nanomolar potency. When inhaled, indacaterol acts locally in the lung as a bronchodilator. In isolated human bronchus, indacaterol has a rapid onset of action and a long duration of action.
	Read more about Indacaterol
2	Mometasone UNII 04201GDN4R - MOMETASONE FUROATE
	Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.
	Read more about Mometasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AK14		R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1821619, 1821620, 1821631, 1821642, 1821653, 1821664, 1821675, 1821686, 1821697, 1821709, 1821710, 1821721
LT	Valstybinė vaistų kontrolės tarnyba	1090350, 1090351, 1090352, 1090353, 1090354, 1090355, 1090356, 1090357, 1090358, 1090359, 1090360, 1090361
PL	Rejestru Produktów Leczniczych	100441899, 100441907, 100441913
ZA	Health Products Regulatory Authority	54/10.2.1/0870.867, 54/10.2.1/0871.868, 54/10.2.1/0872.869